Bank of New York Mellon Corp Cuts Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Bank of New York Mellon Corp decreased its holdings in Semler Scientific, Inc. (NASDAQ:SMLR) by 5.2% in the fourth quarter, HoldingsChannel.com reports. The firm owned 16,611 shares of the company’s stock after selling 907 shares during the quarter. Bank of New York Mellon Corp’s holdings in Semler Scientific were worth $897,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Verition Fund Management LLC acquired a new position in shares of Semler Scientific during the 3rd quarter worth approximately $251,000. Principal Financial Group Inc. increased its holdings in Semler Scientific by 633.1% in the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company’s stock worth $6,074,000 after acquiring an additional 97,144 shares in the last quarter. Geode Capital Management LLC raised its position in Semler Scientific by 10.5% during the third quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock worth $3,202,000 after acquiring an additional 12,964 shares during the period. IFP Advisors Inc purchased a new position in Semler Scientific during the fourth quarter valued at $54,000. Finally, Jane Street Group LLC grew its position in shares of Semler Scientific by 72.3% in the third quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock valued at $400,000 after purchasing an additional 7,126 shares during the period. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Analysts Set New Price Targets

Separately, Lake Street Capital upped their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research report on Friday, January 24th.

Semler Scientific Price Performance

NASDAQ SMLR opened at $42.38 on Wednesday. The stock’s 50 day simple moving average is $46.78 and its 200-day simple moving average is $44.62. The company has a market cap of $406.72 million, a PE ratio of 8.63 and a beta of 1.33. Semler Scientific, Inc. has a 1-year low of $20.88 and a 1-year high of $81.56.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.